1
Conclusions: Copeptin is a new prognostic marker in patients with an ICH.
2
Objective: Presepsin is highlighted as a diagnostic and prognostic marker of sepsis.
3
Conclusion: BNP is considered an established prognostic marker for heart failure patients.
4
Evidence that EBV is a meaningful prognostic marker may have therapeutic relevance.
5
Romo1 overexpression could be a potential adverse prognostic marker in this setting.
6
LKB1 expression may be a useful prognostic marker in human breast cancer.
7
Mesothelin is a potential therapeutic target and prognostic marker in breast cancer.
8
Conclusion: hTERT level is an independent prognostic marker of OS in CRC patients.
9
Hence, we propose that sst2 expression represents a new prognostic marker for NB.
10
We investigated the possible role of APF as a prognostic marker in RA.
11
Secondary objectives included prospective determination of LOH as a prognostic marker in OPLs.
12
MR-proADM is a strong prognostic marker in patients with cardiovascular disease.
13
Thus ANXA5 could serve as a prognostic marker for tumor progression.
14
Cystatin C has been explored as a valuable prognostic marker in several malignancies.
15
Analysis also confirmed that PTX3 is a prognostic marker after AMI.
16
Rationale: Airway responsiveness is a prognostic marker for asthma symptoms in later life.
